Literature DB >> 6187129

Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.

J J Schlesinger, M W Brandriss, T P Monath.   

Abstract

Nineteen monoclonal antibodies were produced to the 17D strain of yellow fever virus (17D YF). Virus-specific structural and nonstructural proteins were identified for 17D YF and for the parent wild Asibi YF by radioimmunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Fourteen of the monoclonal antibodies were directed against the envelope glycoprotein, E, and five against the nonstructural protein gp 48. The E protein of 17D YF was resolved as a double complex whereas the E protein of Asibi YF appeared as a single band of slightly lower molecular weight. The only IgM anti-E antibody obtained precipitated and neutralized 17D YF specifically with no activity against Asibi YF. This antibody also distinguished clearly by neutralization (N) between the 17D-204 derived vaccine strain to which the animal had been immunized and 17D YF strains of different origin. All 13 IgG anti-E monoclonal antibodies had hemagglutination-inhibition (HI) activity to 17D YF and all but one neutralized Asibi YF; however, only 3 of the 13 neutralized 17D YF. Four anti-E antibodies cross-reacted with other flaviviruses by HI or HI and N. Three of the five anti-gp 48 antibodies had complement-fixation (CF) titers against 17D YF and Asibi YF but none had N or HI activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187129     DOI: 10.1016/0042-6822(83)90059-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.

Authors:  B K Sil; L M Dunster; T N Ledger; M R Wills; P D Minor; A D Barrett
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.

Authors:  Y S Hahn; E M Lenches; R Galler; C M Rice; J Dalrymple; J H Strauss
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Comparative immunochemical and biological analysis of African and South American yellow fever viruses.

Authors:  V Deubel; J J Schlesinger; J P Digoutte; M Girard
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Authors:  Lucie Fénéant; Julie Potel; Catherine François; Famara Sané; Florian Douam; Sandrine Belouzard; Noémie Calland; Thibaut Vausselin; Yves Rouillé; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Dimitri Lavillette; Didier Hober; Jean Dubuisson; Czeslaw Wychowski; Laurence Cocquerel
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication.

Authors:  B D Lindenbach; C M Rice
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation.

Authors:  I R Muylaert; R Galler; C M Rice
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.

Authors:  Brett A Thibodeaux; Nina C Garbino; Nathan M Liss; Joseph Piper; Jacob J Schlesinger; Carol D Blair; John T Roehrig
Journal:  Antiviral Res       Date:  2012-02-15       Impact factor: 5.970

8.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

9.  Typing of cytopathic and noncytopathic bovine viral diarrhea virus reference and Canadian field strains using a neutralizing monoclonal antibody.

Authors:  R Magar; H C Minocha; C Montpetit; P S Carman; J Lecomte
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

10.  Anamnestic immune response to dengue and decreased severity of yellow Fever.

Authors:  Ricardo O Izurieta; Maurizio Macaluso; Douglas M Watts; Robert B Tesh; Bolivar Guerra; Ligia M Cruz; Sagar Galwankar; Sten H Vermund
Journal:  J Glob Infect Dis       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.